Pfizer Cuts Initial COVID-19 Vaccine Rollout By Half
Pfizer says supply chain issues are one reason it reduced its production target for a COVID-19 vaccine.
Pfizer says supply chain issues are one reason it reduced its production target for a COVID-19 vaccine. That's according to the Wall Street journal.
The drugmaker's initial goal was 100 million doses by the end of the year. But in recent weeks, Pfizer said that target is now 50 million. The company says it's still on track to get a billion vaccine doses out in 2021.
The United Kingdom approved Pfizer's vaccine candidate this week and plans to start vaccinations Monday.
Here in the U.S., the FDA is reviewing the Pfizer and Moderna candidates for emergency use. And states are getting ready to go.
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
New data links COVID-19 pandemic's origins to raccoon dogs
The discovery does not prove that raccoon dogs or any other animals infected with COVID triggered the pandemic.
Are video games contributing to gambling problems?
Experts say the legalization of gambling, especially in mobile settings, is leading to a blurrier line between that and video games.
Ukrainian mom's visit to the US turned into a mission to help refugees
What started as visit to her son in Chicago is now a mission to help other Ukrainian refugees settle in the Windy City.
Woman sues artificial tears maker after loss of eyeball
Ezricare's artificial tears have been linked to a bacterial infection that is causing blindness, loss of eyes and even death.